Children’s Oncology Group’s Project: EveryChild

APEC14B1: Project:Every Child, A Registry, Eligibility Screening, Biology and Outcome Study

Protocol Description

This Children's Oncology Group program is being conducted to find better ways to diagnose, treat, and prevent cancers in children, adolescents, and young adults. As most cancers that children get are rare, researchers can best learn by combining information from as many children with cancer as possible. Project:EveryChild creates a childhood cancer registry, tracks outcomes, and provides a means for researchers to contact participants regarding potential participation in future relevant research programs.

Eligibility Criteria

With certain exceptions, this study is enrolling patients ages 25 and younger at the time of their cancer diagnosis, provided enrollment occurs within 6 months of initial disease presentation or within 6 months of refractory disease, disease progression, recurrence or secondary malignancy. Older participants may be enrolled on Project:EveryChild if they are being screened for eligibility on qualifying studies for which there is a higher age limit.
Males and Females: Up through 25 years of age in most cases


The study collects information at the time of each participant’s regular medical care visit. Updated health information will be periodically provided to the study doctors for up to 10 years. Tissue, blood samples and genetic material collected through clinical procedures, along with DNA samples from parents who grant permission, will be included in the Project:EveryChild biorepository to be used in future research.
Visits: Not applicable
Duration: Up to 10 years for data collection

Status: Open to Enrollment

Source(s) of Support

Children’s Oncology Group (APEC14B1)
National Cancer Institute

Primary Investigator

Jean M. Tersak, MD

Contact Information

For more information about the study, please contact the UPMC Children’s Hospital of Pittsburgh Hematology-Oncology research team, at: